Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
New York, New York--(Newsfile Corp. - May 5, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Emergent Biosolutions Inc. (NYSE:
EBS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Emergent Biosolutions Inc.
12:59pm, Wednesday, 05'th May 2021
New York, New York--(Newsfile Corp. - May 5, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Emergent Biosolution
Los Angeles, California--(Newsfile Corp. - May 5, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Emergent BioSolutions
New York, New York--(Newsfile Corp. - May 5, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Emergent Biosolutions Inc. (NYSE: EBS) alleg
NEW YORK, May 4, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between July 6, 2020 thr
Why Emergent BioSolutions Stock Dropped 30% in April
04:50pm, Tuesday, 04'th May 2021
The company went from hero to zero in the fight against COVID-19.
New York, New York--(Newsfile Corp. - May 4, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Emer
Los Angeles, California--(Newsfile Corp. - May 4, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Emergent BioSolutions
New York, New York--(Newsfile Corp. - May 4, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Emergent BioSolutions Inc. ("Emergent" or
Is Emergent BioSolutions Still a Buy After Its Coronavirus Vaccine Flub?
06:33am, Tuesday, 04'th May 2021
Shareholders beware: The hits just won't stop coming.
Emergent BioSolutions: Punished For Answering The Call To Immediate Action
10:49pm, Monday, 03'rd May 2021
Emergent BioSolutions has had a rough go over the past couple of months resulting from a cross-contamination mishap at their Baltimore facility. Due to the cross contamination, the company had to toss
New York, New York--(Newsfile Corp. - May 3, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Emergent Biosolutions Inc. (NYSE: EBS) alleg
Radnor, Pennsylvania--(Newsfile Corp. - May 3, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of Emergent BioSolutions Inc. (NYSE: EBS) ("Emergent") that a securities fra
Los Angeles, California--(Newsfile Corp. - May 3, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Emergent BioSolutions
New York, New York--(Newsfile Corp. - May 3, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Emer
